PTC Therapeutics buys ST-920 from Sangamo Therapeutics
PTC Therapeutics, Inc. Acquirer · Sangamo Therapeutics, Inc. Seller
The deal
- Type
- Acquisition
- Amount
- Not recorded
- Status
- Closed
- Valuation
- Not recorded
- Region
- United States
- Date
- 21 September 2026
As of this development: a later development may record new terms.
Lifecycle
- Announced
- Closed
The parties
PTC Therapeutics, Inc. Acquirer
Sangamo Therapeutics, Inc. Seller